Infosys GenAI: CLSA sees $300-400bn market by 2030

Why Infosys is back in focus

Infosys Ltd is likely to remain in focus after brokerage CLSA reiterated its positive stance on the stock, pointing to the company’s positioning in generative artificial intelligence services. The brokerage kept an Outperform rating and published a target price of ₹1,512 per share, which it said implies over 32% upside from prevailing levels cited in the report. The note lands at a time when investors are trying to separate long-term AI opportunity from near-term uncertainty in IT spending. Infosys has also been in the news for its AI-related investor communication, including an AI-first framework and its Topaz suite. Market moves around the stock have been mixed, with one update noting the stock ended 3.08% lower at ₹1,144 on Wednesday, partly reflecting an ex-dividend adjustment.

What CLSA said on GenAI and the target price

CLSA’s core argument is that Infosys is well placed to benefit from what it estimates could be a USD 300-400 bn GenAI opportunity by 2030. The brokerage also highlighted that Infosys is emerging as a leader in adopting GenAI compared with peers. In one version of the report summary, CLSA’s target price was stated as ₹1,512 with an Outperform rating. In another market wrap included in the provided text, CLSA was described as relatively more cautious, still with an Outperform view but with a target of ₹1,779, and a separate line again reiterated a target of ₹1,779 implying about 11% upside. Since these figures appear across different updates, the consistent takeaway is CLSA’s constructive view on Infosys’ AI positioning, with target prices cited in the ₹1,512 to ₹1,779 range in the material provided.

The market size assumption: USD 300-400 bn by 2030

The USD 300-400 bn figure is central to multiple brokerage comments included in the text and is framed as an “AI-first services” or GenAI services spend opportunity by calendar year 2030. The estimates are positioned as incremental or expanding spend pools, led by themes such as process automation and agentic modernisation of legacy systems. This matters because large IT services contracts tend to follow multi-year cycles, and brokerages are attempting to map a new category of spending onto the existing services model. The provided reports treat GenAI not as a narrow software product category, but as a services-led opportunity that can cut across consulting, modernisation, operations, and managed services.

Infosys’ current GenAI traction: USD 1 bn and a 5.5% share

CLSA’s note, as summarised in the provided text, says Infosys is already making around USD 1 bn in revenue from GenAI-focused services. Another update in the same material adds that the new AI services opportunity is already at 5.5% of revenues in 3Q26. A separate line says GenAI is now about “5 and a half percent” of overall revenue, described as a new detail for the market. These points are being used by brokerages to argue that AI adoption is not just aspirational, but already present in delivery and commercial conversations.

AI Investor Day: framework, Topaz suite, and enterprise readiness

The text also references Infosys unveiling its “AI First Value Framework” and the Topaz suite, described as a generative and agentic AI offering. One wrap notes that this move is expected to enable the company to tap into an incremental AI-first services opportunity of USD 300-400 bn by 2030. Another update mentions “more than 600 out-of-the-box agents” designed to integrate with clients’ existing technology landscapes. At the same time, at least one brokerage caution in the provided material (UBS) flagged that while the AI opportunity is expanding, “organisations are not ready,” implying adoption and execution could vary across clients.

Stock movement: ex-dividend adjustment and post-event reaction

One report snapshot says Infosys shares ended 3.08% lower at ₹1,144 on Wednesday, partly reflecting the stock’s ex-dividend adjustment. Another market update in the text says the stock “tumbled more than 3% to ₹1,346 on the NSE” after a sweeping AI roadmap, indicating investor caution despite the longer-term narrative. Taken together, the provided material suggests the market is still negotiating how quickly AI positioning converts into near-term earnings and whether productivity benefits translate into revenue expansion or pricing pressure.

How other brokerages are positioned

Beyond CLSA, the provided text lists several brokerage views and target prices, suggesting broad optimism but different assumptions on pace and monetisation. JPMorgan is described as the most bullish in one summary, maintaining an Overweight rating with a target price of ₹2,050, and noting the “six-sided AI new services opportunity.” Motilal Oswal reiterated a Buy call with a target of ₹1,850, and referenced partnerships with AI-native firms such as Cognition, Cursor, and Anthropic. Nuvama maintained a Buy rating with a target of ₹1,900 while acknowledging that revenue compression due to AI-driven productivity could be front-loaded, with benefits accruing later. Morgan Stanley maintained an Equal Weight rating with a target price of ₹1,760.

Key facts at a glance

Broker target prices mentioned in the text

Market impact and what investors are debating

A recurring debate in the provided reports is whether AI-led productivity will compress revenue in the near term, as efficiency gains are passed on to clients, even as long-term wallet share could rise if delivery quality improves. Some brokerages argue that concerns about disruption from GenAI have been exaggerated, while others highlight that adoption readiness varies and may slow conversion of pipeline into billable work. The mix of target prices in the text suggests that the market is broadly constructive on AI as a demand driver, but divided on timing and margin-throughput. Infosys’ disclosure that AI services are already a mid-single-digit share of revenue in 3Q26 is being used as evidence of traction.

What to watch next

The next checkpoints will likely be how Infosys updates investors on AI-related deal wins, conversion of pilots into scaled programs, and how it frames pricing and productivity effects in guidance commentary. Broker notes included in the text also reference better revenue visibility into FY27, making upcoming communication on demand and execution an important watch item. For the stock, attention will remain on whether AI announcements translate into measurable growth and whether the broader IT sector’s valuation and sentiment stabilise.